Hangzhou Jeci Biochem Technology Co., Ltd. is located in the heart of China’s pharmaceutical innovation hub, Hangzhou, Zhejiang Province. As a premier provider of GLP-1 Agonist OEM/ODM services, we are committed to the sales of active pharmaceutical ingredients (APIs), pharmaceutical intermediates, nutritional products, and food additives.
Our expertise extends beyond simple supply; we offer specialized cooperative R&D, custom manufacturing, and comprehensive import-export services. In the rapidly evolving landscape of metabolic health, we stand as a cornerstone for businesses looking to scale their production of high-purity peptides and complex chemical materials.
The global pharmaceutical industry is witnessing an unprecedented surge in demand for Glucagon-like peptide-1 (GLP-1) receptor agonists. Originally developed for Type 2 Diabetes management, these compounds have emerged as the "gold standard" for weight management and metabolic health. As of 2024, the market for GLP-1 agonists is projected to grow triple-fold by 2030, driven by an increasing global focus on obesity prevention and chronic disease management.
Shift from injectable to oral GLP-1 formulations.
Surging procurement from North America, EU, and SE Asia.
Need for high-capacity, GMP-compliant OEM factories.
From the industrial procurement perspective, international pharmaceutical giants and biotech startups alike are seeking reliable OEM/ODM partners in China. This is due to China’s mature chemical synthesis infrastructure and the ability to produce high-purity GLP-1 intermediates at scale. At Hangzhou Jeci Biochem, we bridge the gap between complex molecular design and mass-market commercialization.
Our facility specializes in the production of high-end chemical materials required for the synthesis of Semaglutide, Tirzepatide, and other GLP-1 analogues. We ensure that every batch of industrial raw materials meets stringent purity standards required for advanced intermediate production.
Leveraging our collaborative R&D team, we work in depth with new drug research institutes to provide technology transfer and custom processing for exclusive regional agents.
China has become the global hub for pharmaceutical intermediate manufacturing. As a leading GLP-1 Agonists Factory, Hangzhou Jeci Biochem offers distinct advantages that help our clients maintain a competitive edge:
We are able to assemble and produce larger quantities of intermediates and provide advanced manufacturing capabilities. For our main product intermediates, we maximize our technical advantages to meet the most demanding customer timelines.
Whether you require a pilot scale for R&D or multi-ton production for global distribution, our equipment and experienced engineering team are equipped to handle the task with AI-driven precision and systematic quality control.
Our drugs and intermediates are widely utilized across several key sectors:
Internationally, we have established long-term trade relations with key markets including India, Southeast Asia, South Korea, and Japan. We don’t just ship products; we provide the whole process of market and sales services, including product registration and sales channel expansion for overseas companies looking to penetrate the Chinese market.
Our localized application scenarios include providing custom-formulated peptides for clinics, hospitals, and pharmaceutical distributors who require specific concentrations and purity levels optimized for their local regulatory requirements.
SJ medical
